DK0848011T3 - Køleelement og køleanordning - Google Patents

Køleelement og køleanordning

Info

Publication number
DK0848011T3
DK0848011T3 DK96203556T DK96203556T DK0848011T3 DK 0848011 T3 DK0848011 T3 DK 0848011T3 DK 96203556 T DK96203556 T DK 96203556T DK 96203556 T DK96203556 T DK 96203556T DK 0848011 T3 DK0848011 T3 DK 0848011T3
Authority
DK
Denmark
Prior art keywords
chr
hydrogen
carbamoyl
integer
amino
Prior art date
Application number
DK96203556T
Other languages
English (en)
Inventor
Peter Hoogerhout
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of DK0848011T3 publication Critical patent/DK0848011T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Polymers (AREA)
  • Cooling Or The Like Of Semiconductors Or Solid State Devices (AREA)
DK96203556T 1996-12-16 1996-12-16 Køleelement og køleanordning DK0848011T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203556A EP0848011B1 (en) 1996-12-16 1996-12-16 Method of coupling polysaccharides to proteins

Publications (1)

Publication Number Publication Date
DK0848011T3 true DK0848011T3 (da) 2001-07-16

Family

ID=8224703

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96203556T DK0848011T3 (da) 1996-12-16 1996-12-16 Køleelement og køleanordning

Country Status (12)

Country Link
US (1) US6361777B1 (da)
EP (1) EP0848011B1 (da)
JP (1) JP4619459B2 (da)
AT (1) ATE199908T1 (da)
AU (1) AU5347898A (da)
CA (1) CA2274852C (da)
DE (1) DE69612205T2 (da)
DK (1) DK0848011T3 (da)
ES (1) ES2156611T3 (da)
GR (1) GR3035918T3 (da)
PT (1) PT848011E (da)
WO (1) WO1998027107A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
RU2005102604A (ru) * 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
JP4696079B2 (ja) 2003-12-17 2011-06-08 ヤンセン アルツハイマー イミュノセラピー Aβ免疫原性ペプチド担体結合物およびそれの製造方法
KR101157694B1 (ko) 2003-12-17 2012-06-20 와이어쓰 엘엘씨 면역원성 펩티드 캐리어 컨쥬게이트 및 이의 제조 방법
JP5666310B2 (ja) * 2008-12-03 2015-02-12 株式会社カネカ ホルミル基含有多孔質担体、それを用いた吸着体、およびそれらの製造方法
EP2924053B1 (en) * 2012-11-22 2020-11-11 Glytech, Inc. Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
WO2014084110A1 (ja) * 2012-11-30 2014-06-05 株式会社糖鎖工学研究所 糖鎖付加リンカー、糖鎖付加リンカーと生理活性物質とを含む化合物またはその塩、及びそれらの製造方法
ES2701169T3 (es) * 2014-02-14 2019-02-21 Pfizer Conjugados glucoproteicos inmunogénicos
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US20240300997A1 (en) * 2021-03-03 2024-09-12 Tohoku University Protein folding agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549051B1 (fr) 1983-06-22 1986-05-16 Centre Nat Rech Scient Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
US4762713A (en) 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant
US5738855A (en) * 1994-10-17 1998-04-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide

Also Published As

Publication number Publication date
JP2001509144A (ja) 2001-07-10
WO1998027107A1 (en) 1998-06-25
ATE199908T1 (de) 2001-04-15
DE69612205T2 (de) 2001-08-30
CA2274852C (en) 2008-06-17
JP4619459B2 (ja) 2011-01-26
DE69612205D1 (de) 2001-04-26
WO1998027107A8 (en) 2000-01-20
EP0848011A1 (en) 1998-06-17
ES2156611T3 (es) 2001-07-01
US6361777B1 (en) 2002-03-26
PT848011E (pt) 2001-08-30
AU5347898A (en) 1998-07-15
GR3035918T3 (en) 2001-08-31
EP0848011B1 (en) 2001-03-21
CA2274852A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
DK0848011T3 (da) Køleelement og køleanordning
ATE64396T1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE342927T1 (de) Nicht-elastomere polyurethanzusammensetzungen
TW200510368A (en) Pharmaceutical compositions and combinations of novel non-imidazole compounds
NO20020725D0 (no) Celleadhesjonsinhibitorer
MXPA02009482A (es) Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino.
MXPA04003828A (es) Novedosos inhibidores de dipeptidil peptidasa iv (dp-iv) como agentes antiabeticos.
ATE296797T1 (de) N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
MX9805289A (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen una afinidad por los receptores de la bradicinina.
NO950377D0 (no) Argatrobanopplösninger
TR200401432T4 (tr) Admantan türevleri
WO2008007113A3 (en) Pharmaceutical combinations
DE69329425D1 (de) Dolastatin analog
TR199701287T1 (xx) Azasikloalkan t�revleri, haz�rlan��lar� ve terapideki uygulamalar�.
GR3035205T3 (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
ATE365722T1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s- triazin, dieser enthaltenden sonnenschutzzusammensetzungen und dessen verwendungen
SE0101344D0 (sv) Iron powder composition
ATE395382T1 (de) Härtbare polymerverbindung
ATE177110T1 (de) Verbesserte b12-konjugate
TW200619250A (en) Resin composition and resin sheet for optical use, and optical semiconductor device
BG101287A (en) Microbicidal composition
HRP20050242B1 (en) Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
WO2003022794A3 (en) Hydroxy-functional esters having terminal acrylate groups
DE60003711D1 (de) Verfahren zur herstellung von peptidzwischenprodukten
NO980392L (no) Polyhydroksyalkylamidaminoksyder